Tolnaftate
/api/v1/drug/tolnaftateMechanism of action
Sourced from openFDAMechanism-of-action class: Squalene Monooxygenase Inhibitors.
Indications
Sourced from openFDA- Uses cures mose athlete's foot (tinea pedis) and ringworm (tinea corporis) prevents recurrence of athlete's foot with daily use relieves itching, burning and crackingICD-10: B35.3
Dosage & administration
Sourced from openFDADirections wash affected area and dry thoroughly shake can well and spray a thin layer over affected area twice daily (morning and night) or as directed by a doctor supervise children in the use of this product for athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily use daily for 4 weeks if conditions persists, consult a doctor this product is not effective on the scalp or nails
Warnings & precautions
Sourced from openFDAFor external use only. Flammable: Keep away from heat, sparks and open flame. Contents under pressure. Do not puncture or incinerate. Do not store at temperature above 120°F. Use only as directed. Intentional misuse by deliberately concentrating and inhaling the contents can be harmful or fatal. When using this product avoid contact with the eyes Stop use and ask a doctor if irritation occurs if there is no improvement within 4 weeks Do not use on children under 2 years of age unless directed by a doctor. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
FAERS reports
- 1Drug Ineffective1228.8%
- 2Pain926.7%
- 3Fatigue866.2%
- 4Nausea846.1%
- 5Dyspnoea815.9%
- 6Diarrhoea735.3%
- 7Anxiety644.6%
- 8Off Label Use594.3%
- 9Headache564.0%
- 10Vomiting543.9%
- 11Acute Kidney Injury523.8%
- 12Pneumonia513.7%
- 13Arthralgia493.5%
- 14Asthenia493.5%
- 15Rash493.5%
Literature
Recent PubMed references pinned to Tolnaftate as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.
- Response to Comment on "Emerging insights and commentaries - MMRM vs LOCF by Naitee Ting".Journal of biopharmaceutical statistics · 2024 · Ting NPMID 37908171DOI 10.1080/10543406.2023.2267648
- Flexosomes as a promising nanoplatform for enhancing tolnaftate ocular delivery: Formulation, in vitro characterization, statistical optimization, ex vivo and microbial in vivo studies.International journal of pharmaceutics · 2023 · Aziz D, Mohamed S, Tayel S, et al.PMID 37793467DOI 10.1016/j.ijpharm.2023.123471
- Comments on "Emerging insights and commentaries - MMRM vs LOCF by Naitee Ting".Journal of biopharmaceutical statistics · 2024 · Wright D, Bratton DJ, Drury T, et al.PMID 37747099DOI 10.1080/10543406.2023.2250853
- Sporotrichosis in Argentina: clinical and epidemiological analysis.Biomedica : revista del Instituto Nacional de Salud · 2023 · Santiso G, Messina F, Arechavala A, et al.PMID 37721908DOI 10.7705/biomedica.6886
- Mycological diagnosis of paracoccidioidomycosis in a hospital from a nonendemic area: classical and molecular methods.Biomedica : revista del Instituto Nacional de Salud · 2023 · Fernández NB, Toranzo A, Farias L, et al.PMID 37721907DOI 10.7705/biomedica.6888
- Are Functional Gains Durable After Decompressive Surgery for Cervical Myelopathy?: Commentary on an article by Victor Hin Ting Yick, MBBS, et al.: "Neurological Survivorship Following Surgery for Degenerative Cervical Myelopathy. A Longitudinal Study on 195 Patients".The Journal of bone and joint surgery. American volume · 2023 · Haft GFPMID 36723469DOI 10.2106/JBJS.22.01250
- Discussion on "Instrumented difference-in-differences" by Ting Ye, Ashkan Ertefaie, James Flory, Sean Hennessy, and Dylan S. Small.Biometrics · 2023 · Beyhum J, Florens JP, Van Keilegom I, et al.PMID 36369777DOI 10.1111/biom.13779
- Discussion on "Instrumented difference-in-differences" by Ting Ye, Ashkan Ertefaie, James Flory, Sean Hennessy & Dylan S. Small.Biometrics · 2023 · Kang HPMID 36346088DOI 10.1111/biom.13784
Clinical trials
The 10 most recently updated of 34 ClinicalTrials.gov registrations naming Tolnaftate as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal DiseaseRecruiting · Interventional · 50 enrolled · University of Wisconsin, MadisonNCT06380075updated 2026-04-24
- Time in rANge vs. Time in nOrmal Glycemia for Better Glycemic ControlNot yet recruiting · Interventional · 120 enrolled · University Hospital, MotolNCT07376850updated 2026-01-29
- Clinical Evaluation of Effectiveness of the "Therm'Up" Heating DeviceEnrolling by invitation · Interventional · 100 enrolled · ThermoTraumaNCT06788925updated 2026-01-14
- Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional StudyRecruiting · Phase 2 · Interventional · 150 enrolled · Propedix, Inc.NCT07245667updated 2025-11-28
- COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic AtrophyCompleted · Interventional · 62 enrolled · University of Wisconsin, MadisonNCT05961332updated 2025-06-11
- Efficacy of Acupuncture Treatment for Breast Cancer-associated InsomniaActive not recruiting · Interventional · 264 enrolled · Yin PingNCT05510700updated 2025-05-22
- Diabetic Retinopathy Classification: ETDRS 7-fields vs Widefield Imaging (ClarusDR)Completed · Observational · 81 enrolled · Association for Innovation and Biomedical Research on Light and ImageNCT05746975updated 2024-11-27
- Clinical and Radio-graphic Evaluation of Non-staining Bio-active Bio-ceramic (Neo MTA 2) in RevascularizationNot yet recruiting · Phase 2 · Interventional · 22 enrolled · Cairo UniversityNCT06637761updated 2024-10-15
- The TearAD Study: Tear Biomarkers for Alzheimer's Disease (AD) Screening and DiagnosisUnknown · Observational · 200 enrolled · Maastricht University Medical CenterNCT05655793updated 2024-03-13
- Biomarkers in Retinitis PigmentosaUnknown · Observational · 35 enrolled · Fondazione Policlinico Universitario Agostino Gemelli IRCCSNCT06306690updated 2024-03-12
Frequently asked questions
- How does Tolnaftate work?
- Mechanism-of-action class: Squalene Monooxygenase Inhibitors.
- What is Tolnaftate used for?
- According to FDA labeling, Tolnaftate carries indications including: Uses cures mose athlete's foot (tinea pedis) and ringworm (tinea corporis) prevents recurrence of athlete's foot with daily use relieves itching, burning and cracking. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
- What class of drug is Tolnaftate?
- Tolnaftate is classified as Other antifungals for topical use, Squalene Monooxygenase Inhibitors, Cellular Growth Phase Arrest.
- What are the brand names for Tolnaftate?
- Tolnaftate is marketed under brand names including Absorbine Jr. Antifungal, Blis-To-Sol, Cidacin, Clarus, Fungi-Gone, Fungi-Guard, Fungi-Nail Reformulated Mar 2019, Fungifoam.
tolnaftate is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.